Rasino Drugs Private Limited - Company Profile

It is a pharma private limited company based in Ambernath, Maharashtra, India, established in 2015.
2015 Ambernath, Maharashtra, India Active
Last Updated:
Access Report
About Rasino Drugs Private Limited

Rasino Drugs Private Limited, a active private limited company, was established on 26 November 2015 in Ambernath, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24233MH2015PTC270493. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.20 M.

It upholds a compliant status. Employing 19 professional, Its leadership includes Paresh Pratap Doshi (Director), Swarada Paresh Doshi (Director). Past directors included Rakesh Shyam Kirpalani, Ajay Charanjit Obhan, Rakhee Vinod Shinde. It holds ₹5.46 Cr open charges and ₹3.00 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2024. It is based at Plot No.N-18, Additional Midc, Anand Nagar, Ambernath, Maharashtra, 421506.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233MH2015PTC270493

  • Registration Number

    270493

  • Incorporation Date

    26 November 2015

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.20 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 10 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 5.46 Cr
  • Satisfied Charges ₹ 3.00 Cr
  • Revenue Growth **** 59.94%
  • Profit Growth **** -416.11%
  • Ebitda **** -24.84%
  • Net Worth -8.94%
  • Total Assets **** 8.10%
Company report

Rasino Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rasino Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rasino Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Paresh Pratap Doshi Director 26 Nov 2015 Current
Swarada Paresh Doshi Director 26 Nov 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 27 Dec 2017 Past
Pramod Abcsdd Additional Director 27 Dec 2017 Past
Pramod Abcsdd Director 29 Nov 2017 Past
Pramod Abcsdd Director 29 Nov 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rasino Drugs.

Rasino Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 59.94% increase. The company also saw a substantial fall in profitability, with a 416.11% decrease in profit. The company's net worth dipped by a decrease of 8.94%.

Rasino Drugs revenue growth over time
Rasino Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 59.94%
*******
*******
*******
*******
Revenue from Operations
*******
 58.24%
*******
*******
*******
*******
Total Assets
*******
 8.10%
*******
*******
*******
*******
Profit or Loss
*******
 -416.11%
*******
*******
*******
*******
Net Worth
*******
 -8.94%
*******
*******
*******
*******
EBITDA
*******
 -24.84%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rasino Drugs?

Unlock access to Rasino Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹54,580,000.00

Satisfied Charges

₹29,980,000.00

Charges Breakdown by Lending Institutions
  • Others : 5.46 Cr
Latest Charge Details
Date Lender Amount Status
04 Jan 2024 Others ₹5.46 Cr Open
22 Apr 2022 Axis Bank Limited ₹2.58 M Satisfied
20 Aug 2018 Axis Bank Limited ₹2.74 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Rasino Drugs?

Rasino Drugs has a workforce of 19 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rasino Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rasino Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rasino Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Rasino Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    The activity A charge with Others of Rs. 54.58 M registered on 04 Jan 2024 with Charge ID 100863896 was modified on 02 Apr 2024. was completed.

  • Balance Sheet

    Rasino Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 54.58 M with Charge ID 100863896 was registered on 04 Jan 2024. was documented.

  • Charges

    Progress on A charge registered on 22 Apr 2022 via Charge ID 100564638 with Axis Bank Limited was fully satisfied on 12 Sep 2023. was documented.

  • Charges

    The activity A charge registered on 20 Aug 2018 via Charge ID 100202369 with Axis Bank Limited was fully satisfied on 12 Sep 2023. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rasino Drugs Private Limited?

The CIN of Rasino Drugs Private Limited is U24233MH2015PTC270493.

Where is Rasino Drugs Private Limited headquartered?

Rasino Drugs Private Limited is headquartered at Plot No.N-18, Additional Midc, Anand Nagar, Ambernath, Maharashtra, 421506.

When was Rasino Drugs Private Limited incorporated?

Rasino Drugs Private Limited was incorporated on 26 November 2015.

Who are the current directors of Rasino Drugs Private Limited?

The current directors of Rasino Drugs Private Limited are

What is the primary industry of Rasino Drugs Private Limited?

The primary industry of Rasino Drugs Private Limited is Manufacturing.

Is Rasino Drugs Private Limited a listed company?

Rasino Drugs Private Limited is unlisted.

What is the capital structure of Rasino Drugs Private Limited?

The authorized capital of Rasino Drugs Private Limited is ₹0.50 M, and the paid-up capital is ₹0.20 M.

What is the compliance status of Rasino Drugs Private Limited?

The compliance status of Rasino Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available